TipRanks
RBC Predicts Over 100% Rally for These 3 Stocks
The news lately is focused on the advent of coronavirus vaccines. First Pfizer announced that it had a product in trials, which was showing a 90% efficacy rate, and now Moderna has joined the chorus, with a vaccine that is showing even higher effectiveness, on the order of 94.5%. Between the two news releases, investors are feeling confident; we may be out of the COVID woods sooner than has been anticipated.In a report on the new vaccine…
Source link
